Anúncio
Anúncio

XTNT

XTNT logo

Xtant Medical Holdings, Inc.

0.69
USD
Patrocinado
-0.01
-1.97%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

0.71

+0.02
+3.21%

Relatórios de Lucros XTNT

Rácio de surpresa positiva

XTNT separação 13 de 28 últimas estimativas.

46%

Próximo Relatório

Data do Próximo Relatório
04 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$31.36M
/
$0.00
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-5.68%
/
-100.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-0.47%
/
-100.00%

Xtant Medical Holdings, Inc. earnings per share and revenue

On 10 de nov. de 2025, XTNT reported earnings of 0.01 USD per share (EPS) for Q3 25, beating the estimate of 0.00 USD, resulting in a 296.08% surprise. Revenue reached 33.26 milhão, compared to an expected 33.35 milhão, with a -0.30% difference. The market reacted with a -0.62% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of 0.00 USD, with revenue projected to reach 31.36 milhão USD, implying an diminuir of -100.00% EPS, and diminuir of -5.68% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06 de jan. de 2026 Para Q2 26
Estimativa
-$0.10
Real
$0.00
Surpresa
+100.00%
FAQ
For Q3 2025, Xtant Medical Holdings, Inc. reported EPS of $0.01, beating estimates by 296.08%, and revenue of $33.26M, -0.3% below expectations.
The stock price moved down -0.62%, changed from $0.76 before the earnings release to $0.76 the day after.
The next earning report is scheduled for 04 de mar. de 2026.
Based on 4 analistas, Xtant Medical Holdings, Inc. is expected to report EPS of -- and revenue of $31.36M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio